26730328|t|Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in rats.
26730328|a|OBJECTIVES: The aim of the present study was to evaluate antioxidant and methyl donor effects of betaine in cerebellum following levodopa and benserazide administration in rats. MATERIALS AND METHODS: Sprague-Dawley male rats were treated with levodopa (LD), betaine (Bet), levodopa plus betaine (LD/Bet), levodopa plus benserazide (LD/Ben), levodopa plus betaine-benserazide (LD/Bet-Ben), and the controls with vehicle for 10 consecutive days, orally. RESULTS: Treatment of rats with LD and benserazide significantly increased total homocysteine in plasma of the LD/Ben group when compared to the other groups. Lipid peroxidation of cerebellum increased significantly in LD-treated rats when compared to the other groups. In contrast, glutathione peroxidase activity and glutathione content in cerebellum were significantly higher in the betaine-treated rats when compared to the LD and LD/Ben groups. Serum dopamine concentration increased significantly in LD-treated rats in comparison with the LD/Ben group. LD/Bet-treated rats also demonstrated significantly higher dopamine levels when compared to the LD/Ben group. CONCLUSION: We observed valuable effects of Bet in combination with LD and benserazide, which routinely were used for Parkinson's disease (PD) treatment, in experimentally-induced oxidative stress and hyperhomocysteinemia in rats. Therefore, it seems that Bet is a vital and promising agent regarding PD for future clinical trials in humans.
26730328	0	7	Betaine	Chemical	MESH:D001622
26730328	60	68	levodopa	Chemical	MESH:D007980
26730328	73	84	benserazide	Chemical	MESH:D001545
26730328	103	107	rats	Species	10116
26730328	206	213	betaine	Chemical	MESH:D001622
26730328	238	246	levodopa	Chemical	MESH:D007980
26730328	251	262	benserazide	Chemical	MESH:D001545
26730328	281	285	rats	Species	10116
26730328	330	334	rats	Species	10116
26730328	353	361	levodopa	Chemical	MESH:D007980
26730328	363	365	LD	Chemical	MESH:D007980
26730328	368	375	betaine	Chemical	MESH:D001622
26730328	377	380	Bet	Chemical	MESH:D001622
26730328	383	391	levodopa	Chemical	MESH:D007980
26730328	397	404	betaine	Chemical	MESH:D001622
26730328	406	408	LD	Chemical	MESH:D007980
26730328	409	412	Bet	Chemical	MESH:D001622
26730328	415	423	levodopa	Chemical	MESH:D007980
26730328	429	440	benserazide	Chemical	MESH:D001545
26730328	442	444	LD	Chemical	MESH:D007980
26730328	445	448	Ben	Chemical	MESH:C492379
26730328	451	459	levodopa	Chemical	MESH:D007980
26730328	465	484	betaine-benserazide	Chemical	-
26730328	486	488	LD	Chemical	MESH:D007980
26730328	489	492	Bet	Chemical	MESH:D001622
26730328	493	496	Ben	Chemical	MESH:C492379
26730328	584	588	rats	Species	10116
26730328	594	596	LD	Chemical	MESH:D007980
26730328	601	612	benserazide	Chemical	MESH:D001545
26730328	643	655	homocysteine	Chemical	MESH:D006710
26730328	673	675	LD	Chemical	MESH:D007980
26730328	676	679	Ben	Chemical	MESH:C492379
26730328	721	726	Lipid	Chemical	MESH:D008055
26730328	781	783	LD	Chemical	MESH:D007980
26730328	792	796	rats	Species	10116
26730328	881	892	glutathione	Chemical	MESH:D005978
26730328	948	955	betaine	Chemical	MESH:D001622
26730328	964	968	rats	Species	10116
26730328	990	992	LD	Chemical	MESH:D007980
26730328	997	999	LD	Chemical	MESH:D007980
26730328	1000	1003	Ben	Chemical	MESH:C492379
26730328	1018	1026	dopamine	Chemical	MESH:D004298
26730328	1068	1070	LD	Chemical	MESH:D007980
26730328	1079	1083	rats	Species	10116
26730328	1107	1109	LD	Chemical	MESH:D007980
26730328	1110	1113	Ben	Chemical	MESH:C492379
26730328	1121	1123	LD	Chemical	MESH:D007980
26730328	1124	1127	Bet	Chemical	MESH:D001622
26730328	1136	1140	rats	Species	10116
26730328	1180	1188	dopamine	Chemical	MESH:D004298
26730328	1217	1219	LD	Chemical	MESH:D007980
26730328	1220	1223	Ben	Chemical	MESH:C492379
26730328	1275	1278	Bet	Chemical	MESH:D001622
26730328	1299	1301	LD	Chemical	MESH:D007980
26730328	1306	1317	benserazide	Chemical	MESH:D001545
26730328	1349	1368	Parkinson's disease	Disease	MESH:D010300
26730328	1370	1372	PD	Disease	MESH:D010300
26730328	1432	1452	hyperhomocysteinemia	Disease	MESH:D020138
26730328	1456	1460	rats	Species	10116
26730328	1487	1490	Bet	Chemical	MESH:D001622
26730328	1532	1534	PD	Disease	MESH:D010300
26730328	1565	1571	humans	Species	9606
26730328	Negative_Correlation	MESH:D007980	MESH:D010300
26730328	Positive_Correlation	MESH:D004298	MESH:D007980
26730328	Negative_Correlation	MESH:D001545	MESH:D010300
26730328	Negative_Correlation	MESH:D001622	MESH:D020138
26730328	Positive_Correlation	MESH:D006710	MESH:D007980
26730328	Cotreatment	MESH:D001622	MESH:D007980
26730328	Cotreatment	MESH:C492379	MESH:D007980
26730328	Positive_Correlation	MESH:D001622	MESH:D005978
26730328	Positive_Correlation	MESH:D007980	MESH:D008055
26730328	Positive_Correlation	MESH:D001545	MESH:D006710
26730328	Negative_Correlation	MESH:D007980	MESH:D020138
26730328	Cotreatment	MESH:D001545	MESH:D007980
26730328	Positive_Correlation	MESH:D001622	MESH:D004298
26730328	Negative_Correlation	MESH:D001622	MESH:D010300
26730328	Positive_Correlation	MESH:D001545	MESH:D020138
26730328	Negative_Correlation	MESH:D001545	MESH:D001622

